Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably.

This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia.

Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients’ health and safety, especially in low- and middle-income regions.

The concept stewardship borrows from collective action problems that cannot be solved by individuals only, just like those discussed in environmental ethics.

Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes.

This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings.

Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”

Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities.

Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD.

Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population.